Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
Domains
Neuroscience| Origin | Files produced by the author(s) |
|---|
Journal Articles
Pharmacology and Therapeutics
Year : 2020
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.science/hal-03598618
Submitted on : Friday, November 29, 2024-4:40:06 PM
Last modification on : Friday, November 29, 2024-4:40:07 PM
Dates and versions
Licence
Identifiers
- HAL Id : hal-03598618 , version 1
- DOI : 10.1016/j.pharmthera.2020.107627
- PII : S0163-7258(20)30157-1
- PUBMED : 32659304
- PUBMEDCENTRAL : PMC7351663
Cite
Françoise Stanke-Labesque, Elodie Gautier-Veyret, Stephanie Chhun, Romain Guilhaumou. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment. Pharmacology and Therapeutics, 2020, 215, pp.107627. ⟨10.1016/j.pharmthera.2020.107627⟩. ⟨hal-03598618⟩
Collections
31
View
6
Download